-
Dexmedetomidine monoclonal antibody adds new indications for advanced gastric cancer
New Beijing News (Reporter Zhang Xiulan) On August 13th, the official website of the National Medical Products Administration (NMPA) showed that the antibody coupled drug (ADC) Uxostat (injectable tr ... -
Merck PD-1 inhibitor CRDA approved for the treatment of locally advanced cervical cancer in China
Merck announced that its PD-1 inhibitor pembrolizumab (trade name: pembrolizumab) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of locally advanc ... -
Merck PD-1 inhibitor CRDA approved for the treatment of locally advanced cervical cancer in China
On December 10th, Merck announced that its PD-1 inhibitor pembrolizumab (trade name: CRDA®) Approved by the National Medical Products Administration (NMPA) of China, the combination of radiothera ... -
Merck PD-1 inhibitor CRDA approved for the treatment of locally advanced cervical cancer in China
According to AI News, on December 10th, Merck announced that its PD-1 inhibitor pembrolizumab (trade name: CRDA& reg;) Approved by the National Medical Products Administration (NMPA) of China, the co ...